Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease

[1]  B. Bacskai,et al.  Bringing amyloid into focus , 2005, Nature Biotechnology.

[2]  Victor L. Villemagne,et al.  Brain Amyloid Imaging , 2011, The Journal of Nuclear Medicine.

[3]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[4]  JaeHyung Koo,et al.  Current status of PET-imaging probes of β-amyloid plaques , 2013, Archives of pharmacal research.

[5]  Boli Liu,et al.  Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits. , 2014, Journal of the American Chemical Society.

[6]  C. Rowe,et al.  Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.

[7]  C. Olbrich,et al.  Optical imaging in drug discovery and diagnostic applications. , 2005, Advanced drug delivery reviews.

[8]  A. Moore,et al.  Spectral Unmixing Imaging of Wavelength-Responsive Fluorescent Probes: An Application for the Real-Time Report of Amyloid Beta Species in Alzheimer’s Disease , 2012, Molecular Imaging and Biology.

[9]  H. Saji,et al.  Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains. , 2012, Journal of medicinal chemistry.

[10]  Christer Halldin,et al.  Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand , 2012, The Journal of Nuclear Medicine.

[11]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[12]  C. Duyckaerts,et al.  PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques. , 2013, ACS medicinal chemistry letters.

[13]  D. E. Clark.  Computational Prediction of Blood-brain Barrier Permeation , 2005 .

[14]  W. Klunk,et al.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.

[15]  M. Cui,et al.  Evaluation of molecules based on the electron donor-acceptor architecture as near-infrared β-amyloidal-targeting probes. , 2014, Chemical communications.

[16]  Seth R. Marder,et al.  Electric Field Modulated Nonlinear Optical Properties of Donor-Acceptor Polyenes: Sum-Over-States Investigation of the Relationship between Molecular Polarizabilities (.alpha., .beta., and .gamma.) and Bond Length Alternation , 1994 .

[17]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[18]  Hank F Kung,et al.  The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing. , 2012, ACS medicinal chemistry letters.

[19]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[20]  R. Baldessarini,et al.  Synthesis, radiolabeling and baboon SPECT imaging of 2β-carbomethoxy-3β-(3′-[123I]iodophenyl)tropane ([123I]YP256) as a serotonin transporter radiotracer , 2008 .

[21]  Shannon M Walsh,et al.  Polyfluorinated Bis-styrylbenzene β-Amyloid Plaque Binding Ligands , 2007 .

[22]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[23]  Brian J Bacskai,et al.  In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers. , 2005, Angewandte Chemie.

[24]  A. Rauk.  The chemistry of Alzheimer's disease. , 2009, Chemical Society reviews.

[25]  Markus Rudin,et al.  In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe , 2005, Nature Biotechnology.

[26]  A. Drzezga,et al.  Development and evaluation of compounds for imaging of β-amyloid plaque by means of positron emission tomography , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  H. Saji,et al.  A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain. , 2011, Bioorganic & medicinal chemistry letters.

[28]  Scott B. Raymond,et al.  Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  Tyler E. Benedum,et al.  Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain , 2009, Journal of Nuclear Medicine.

[30]  H. Kung,et al.  F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. , 2005, Nuclear medicine and biology.

[31]  Jianhua Jia,et al.  (99m)Tc-labeled dibenzylideneacetone derivatives as potential SPECT probes for in vivo imaging of β-amyloid plaque. , 2013, European journal of medicinal chemistry.

[32]  G. Small,et al.  Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease , 2001, The Journal of Neuroscience.

[33]  Lin Zhu,et al.  PET/SPECT imaging agents for neurodegenerative diseases. , 2014, Chemical Society reviews.

[34]  A. Schmidt,et al.  Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. , 2012, Journal of Alzheimer's disease : JAD.

[35]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[36]  Alan A. Wilson,et al.  Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain. , 2003, Journal of medicinal chemistry.

[37]  H. Saji,et al.  Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques. , 2010, Bioorganic & Medicinal Chemistry Letters.

[38]  V. Ntziachristos.  Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[39]  I. Hamley.  The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.

[40]  Sarah C P Williams.  Alzheimer's imaging agents struggle to find a market outside trials , 2013, Nature Medicine.

[41]  E. Salmon,et al.  18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial , 2010, Annals of neurology.

[42]  Satoshi Ito,et al.  In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265. , 2011, Journal of Alzheimer's disease : JAD.

[43]  Zeng Li,et al.  Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease. , 2013, Journal of the American Chemical Society.

[44]  B. Koksch,et al.  Specific in situ discrimination of amyloid fibrils versus α-helical fibres by the fluorophore NIAD-4. , 2012, Molecular bioSystems.

[45]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[46]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[47]  Jin Li,et al.  Detection of Aβ Plaques by a Novel Specific MRI Probe Precursor CR‐BSA‐(Gd‐DTPA)n in APP/PS1 Transgenic Mice , 2010, Anatomical record.

[48]  John Seibyl,et al.  Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.

[49]  H. Kung,et al.  18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. , 2007, Nuclear medicine and biology.

[50]  Masashi Yoshimura,et al.  Molecular Imaging of β-Amyloid Plaques with Near-Infrared Boron Dipyrromethane (BODIPY)-Based Fluorescent Probes , 2013, Molecular imaging.

[51]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[52]  W. Klunk,et al.  Development of positron emission tomography β-amyloid plaque imaging agents. , 2012, Seminars in nuclear medicine.

[53]  K. P. Kepp,et al.  Bioinorganic chemistry of Alzheimer's disease. , 2012, Chemical reviews.

[54]  Alan A. Wilson,et al.  11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. , 2003, Nuclear medicine and biology.

[55]  Alan A. Wilson,et al.  In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[56]  Lars Farde,et al.  Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand , 2010, Journal of neurochemistry.

[57]  E. Nesterov,et al.  Near-infrared fluorophores containing benzo[c]heterocycle subunits. , 2008, Organic letters.

[58]  James Robert Brašić,et al.  In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18) , 2010, Journal of Nuclear Medicine.

[59]  Hiroyuki Kimura,et al.  BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques. , 2012, ACS chemical neuroscience.

[60]  Mengchao Cui,et al.  Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain. , 2013, Current medicinal chemistry.

[61]  A. Moore,et al.  Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta Species , 2011, PloS one.

[62]  D. Selkoe,et al.  The origins of Alzheimer disease: a is for amyloid. , 2000, JAMA.

[63]  Lars Farde,et al.  AZD2184: a radioligand for sensitive detection of β‐amyloid deposits , 2009, Journal of neurochemistry.

[64]  Jeffrey S Derrick,et al.  The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease. , 2014, Accounts of chemical research.

[65]  Chongzhao Ran,et al.  Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins. , 2013, Current organic chemistry.